Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Discovery of the cellular origin of Ewing’s sarcoma

16.05.2007
Inserm researchers at the Institut Curie have identified the cells that cause Ewing’s sarcoma. They are cells of the mesenchyme, the connective tissue that supports other tissues. The Institut Curie is the reference center in France for Ewing’s sarcoma, a bone tumor of children, adolescents, and young adults.

The researchers have also succeeded “to make” the tumor cells to become virtually normal mesenchymal cells again. These results, published in Cancer Cell on 7 May 2007, open up new therapeutic possibilities for blocking the development of Ewing’s sarcoma in young patients.

Ewing’s sarcoma (1) is the second most frequent malignant bone tumor in France, with 50 to 100 new cases a year. It occurs in children, teenagers, and young adults (up to 30 years of age), at a frequency that peaks around puberty, between 10 and 20 years of age. This bone tumor essentially grows in the pelvis, ribs, femur, fibula, and tibia. It is highly invasive and metastases are common, especially in the lungs and skeleton.

Treatment of Ewing’s sarcoma, has progressed greatly in the last thirty years. Nowadays, the therapeutic strategy used in most cases combines chemotherapy, radiotherapy and surgery. The Institut Curie is the reference center for Ewing’s sarcoma in France, and is internationally renowned both for clinical management of patients and research into this disease.

... more about:
»Ewing’s »Inserm »mesenchymal »sarcoma »therapeutic

New therapeutic leads

Cancers rarely have a simple molecular signature—a specific mutation that causes tumor growth. In the case of Ewing’s sarcoma, a molecular signature was identified and characterized in 1992 by Olivier Delattre’s Inserm team at the Institut Curie. It is an accidental change of genetic material between two chromosomes, which results in the formation of a mutant gene, which codes for an abnormal protein called EWS/FLI-1. This discovery led on to the development of a diagnostic test for Ewing’s sarcoma in 1994. Yet until now, the nature of the cell in which this mutation occurs was unknown.

The group of Olivier Delattre, the Director of Inserm Unit 830 “Genetics and Biology of Cancer” at the Institut Curie, and the team of Pierre Charbord, the Director of Inserm Laboratory ERI5 “Microenvironment of Hematopoiesis and Stem Cells” in Tours, have now discovered that Ewing’s sarcoma are caused by cells of the mesenchyme, a connective tissue that supports other tissues. They have shown that the profile of the transcriptome (2) of Ewing’s sarcoma ressemble that of mesenchymal cells, particularly mesenchymal stem cells, when EWS/FLI-1 is inhibited.

By inhibiting the abnormal protein EWS/FLI-1 that causes Ewing’s sarcoma, the researchers also “forced” the tumor cells to return to their original status of mesenchymal stem cells, which can then differentiate normally into bone or fat cells. This approach opens up new therapeutic prospects, since by forcing the cells to resume their original function it may be possible in the future to make them less aggressive and prevent their proliferation. As long as the tumor cells are still able to fulfill their function, they generally proliferate slowly, and the prognosis is good; once they lose this capacity, however, the tumor cells become highly aggressive.

This discovery could allow Delattre, Charbord and colleagues to produce an animal model of Ewing’s sarcoma, an essential stage in the development of new treatments.

These results, published in the May 7 issue of Cancer Cell, show once more that the close collaboration at the Institut Curie between physicians and researchers is vital to advances in treatments of Ewing’s sarcoma.

Catherine Goupillon | alfa
Further information:
http://www.curie.fr
http://www.cancercell.org/

Further reports about: Ewing’s Inserm mesenchymal sarcoma therapeutic

More articles from Life Sciences:

nachricht Fine organic particles in the atmosphere are more often solid glass beads than liquid oil droplets
21.04.2017 | Max-Planck-Institut für Chemie

nachricht Study overturns seminal research about the developing nervous system
21.04.2017 | University of California - Los Angeles Health Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>